Valuation: Evogene Ltd.

Market Cap 4.07M 0 3.57M 3.29M 3.08M 5.78M 384M 5.9M 39.55M 15.31M 190M 15.29M 14.96M 658M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 4.07M 0 3.57M 3.29M 3.08M 5.78M 384M 5.9M 39.55M 15.31M 190M 15.29M 14.96M 658M EV / Sales 2026 *
2.74x
EV / Sales 2027 * 1.57x
Free-Float
82.9%
Yield 2026 *
-
Yield 2027 * -
1 day-2.82%
1 week-26.41%
Current month-40.55%
1 month-40.73%
3 months-54.66%
6 months-63.58%
Current year-60.98%
1 week 115.1
Extreme 115.1
181.3
1 month 115.1
Extreme 115.1
248
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
499
3 years 115.1
Extreme 115.1
6,104
5 years 115.1
Extreme 115.1
11,610
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 30/11/2004
Corporate Officer/Principal - 31/12/2021
Corporate Officer/Principal - 31/12/2025
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 02/06/2010
Chairman 60 31/05/2021
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Executive/Senior Manager

20,000 0.2294%
03-17Other

Chief Technology Officer

57,750 0.6624%
03-17Other

Director

18,900 0.2168%
Change 5-day change 1-year change 3-year change Capi.($)
-2.82%-26.41%-74.31%-97.15% 4.07M
-0.48%+7.20%-5.65%+1.02% 46.2B
+2.19%+11.71%+393.31%+580.42% 38.71B
+2.53%+13.93%+21.38%-12.81% 31.9B
+1.65%+3.61%+16.04%+55.62% 31.12B
-4.16%-2.58%+8.94%+25.31% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+69.64%+130.07% 15.05B
+1.00%+10.30%+13.31%+20.31% 13.74B
+3.63%+9.53%+103.97%+98.73% 13.42B
Average +0.46%+5.58%+60.74%+89.06% 23.01B
Weighted average by Cap. +0.75%+8.71%+88.74%+130.89%

Financials

2026 *2027 *
Net sales 1.48M 0 1.3M 1.2M 1.12M 2.11M 140M 2.15M 14.42M 5.58M 69.19M 5.57M 5.45M 240M 2.6M 0 2.28M 2.1M 1.97M 3.69M 245M 3.77M 25.26M 9.77M 121M 9.76M 9.55M 420M
Net income -16.69M -0 -14.63M -13.49M -12.63M -23.68M -1.57B -24.17M -162M -62.72M -778M -62.66M -61.29M -2.7B -13.92M -0 -12.2M -11.25M -10.53M -19.74M -1.31B -20.15M -135M -52.3M -649M -52.25M -51.11M -2.25B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
26/06/26 ILA 117.30 -2.82% 67,029
25/06/26 ILA 120.70 -6.14% 258,699
24/06/26 ILA 128.60 -13.40% 725,460
23/06/26 ILA 148.50 -5.53% 53,862
22/06/26 ILA 157.20 -1.38% 26,444

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock